Sensitization of TNF-induced cytotoxicity in lung cancer cells by concurrent suppression of the NF-κB and Akt pathways
- 13 April 2007
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 355 (3), 807-812
- https://doi.org/10.1016/j.bbrc.2007.02.030
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Cisplatin activates Akt in small cell lung cancer cells and attenuates apoptosis by survivin upregulationInternational Journal of Cancer, 2005
- Signaling to NF-κBGenes & Development, 2004
- The IKK NF-κB system: a treasure trove for drug developmentNature Reviews Drug Discovery, 2004
- PI3K/Akt and apoptosis: size mattersOncogene, 2003
- Signalling pathways of the TNF superfamily: a double-edged swordNature Reviews Immunology, 2003
- Tumor necrosis factor signalingCell Death & Differentiation, 2003
- The phosphatidylinositol 3-Kinase–AKT pathway in human cancerNature Reviews Cancer, 2002
- PTEN Blocks Tumor Necrosis Factor-induced NF-κB-dependent Transcription by Inhibiting the Transactivation Potential of the p65 SubunitPublished by Elsevier BV ,2002
- Kinase regulation in inflammatory responseNature, 2000
- A Phosphatidylinositol 3-Kinase/Akt Pathway, Activated by Tumor Necrosis Factor or Interleukin-1, Inhibits Apoptosis but Does Not Activate NFκB in Human Endothelial CellsPublished by Elsevier BV ,2000